FDU-PB-22
Systematic (IUPAC) name | |
---|---|
naphthalen-1-yl 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylate | |
Legal status | |
Legal status |
|
Identifiers | |
ChemSpider | 29763739 |
UNII | 85E88884ZQ |
Chemical data | |
Formula | C26H18FNO2 |
Molar mass | 395.42 g/mol |
| |
|
FDU-PB-22 is an derivative of JWH-018 that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a "legal high".[1][2]
Legal status
FDU-PB-22 is a controlled substance in Germany and is banned in Japan and Sweden.[3]
See also
References
- ↑ "FDU-PB-22". Southern Association of Forensic Scientists. Retrieved 23 July 2015.
- ↑ Nahoko Uchiyama, Yoshihiko Shimokawa, Ruri Kikura-Hanajiri, Yosuke Demizu, Yukihiro Goda, Takashi Hakamatsuka (February 2015). "A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products". Forensic Toxicology. doi:10.1007/s11419-015-0268-7.
- ↑ "Cannabinoider föreslås bli klassificerade som hälsofarlig vara". Folkhälsomyndigheten. 28 May 2014. Retrieved 23 July 2015.
This article is issued from Wikipedia - version of the Monday, April 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.